📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: EsoBiotec

1.1 - Company Overview

EsoBiotec Logo

EsoBiotec

Headquarter: Belgium
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology solutions focused on the discovery of novel cancer therapies, aiming to enable the human body to fight cancer through in vivo cell engineering.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to EsoBiotec

Zyngenia Logo

Zyngenia

HQ: United States Website
  • Description: Provider of biotherapeutics focused on the development of next-generation antibody-derived drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zyngenia company profile →
PharmaMar Logo

PharmaMar

HQ: Spain Website
  • Description: Provider of oncology medicines inspired by the sea, discovering antitumor molecules from marine organisms through integrated research and development. Delivers innovative products to equip healthcare professionals with new tools to treat cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full PharmaMar company profile →
Noviga Research Logo

Noviga Research

HQ: Sweden Website
  • Description: Provider of research and development of small molecules aimed at new, more effective cancer treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Noviga Research company profile →
Compass Therapeutics Logo

Compass Therapeutics

HQ: United States Website
  • Description: Provider of immune system–targeting therapeutics and antibody engineering platforms. Pipeline: CTX-009, a DLL4/VEGF-A bispecific showing benefit in colorectal and gastric cancers; CTX-471, a CD137 agonist for melanoma with U.S. studies planned H2 2024; and CTX-8371, a PD-1/PD-L1 bispecific in preclinical development for solid tumors. Platforms: StitchMabs for bispecifics, common light chain discovery, and human display for antibody tuning.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Compass Therapeutics company profile →
Azanta Logo

Azanta

HQ: Denmark Website
  • Description: Provider of pharmaceutical marketing and distribution services, offering a portfolio that includes Amnisure, Cicatridina, Repadina Plus, Cystistat, Flexi-T, Methadone, Oxandrin, Suplasyn, and development products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Azanta company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for EsoBiotec

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to EsoBiotec

2.2 - Growth funds investing in similar companies to EsoBiotec

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for EsoBiotec

4.2 - Public trading comparable groups for EsoBiotec

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to EsoBiotec

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About EsoBiotec

What does EsoBiotec do?

EsoBiotec is a provider of biotechnology solutions focused on the discovery of novel cancer therapies, aiming to enable the human body to fight cancer through in vivo cell engineering.

Who are EsoBiotec's competitors?

EsoBiotec's competitors and similar companies include Zyngenia, PharmaMar, Noviga Research, Compass Therapeutics, and Azanta.

Where is EsoBiotec headquartered?

EsoBiotec is headquartered in Belgium.

How many employees does EsoBiotec have?

EsoBiotec has 1,000 employees 🔒.

When was EsoBiotec founded?

EsoBiotec was founded in 2010 🔒.

What sector and industry vertical is EsoBiotec in?

EsoBiotec is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for EsoBiotec

Who are the top strategic acquirers in EsoBiotec's sector and industry

Top strategic M&A buyers and acquirers in EsoBiotec's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for EsoBiotec?

Top strategic M&A buyers groups and sectors for EsoBiotec include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in EsoBiotec's sector and industry vertical

Which are the top PE firms investing in EsoBiotec's sector and industry vertical?

Top PE firms investing in EsoBiotec's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in EsoBiotec's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in EsoBiotec's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in EsoBiotec's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to EsoBiotec include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in EsoBiotec's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for EsoBiotec?

The key public trading comparables and valuation benchmarks for EsoBiotec include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for EsoBiotec for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for EsoBiotec with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in EsoBiotec's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for EsoBiotec with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in EsoBiotec's' sector and industry vertical?

Access recent funding rounds and capital raises in EsoBiotec's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for EsoBiotec